Congratulations to our portfolio company, NanoSyrinx, for winning the inaugural AbbVie UK Golden Ticket Award! Read more: lnkd.in/dAdmhxm7

Our #AbbVieUKGoldenTicket programme was a collaboration with the @pioneergroup, to support the UK life sciences vision. We are so happy to support our winners @nanosyrinx in their aim to develop ground-breaking technology. Read more about our partnership: bit.ly/3frWEGu

Some bacteria produce tiny syringes to deliver protein into cells, making these #nanosyringes an exciting new tool for protein #DrugDelivery. Stephanie DeMarco, PhD talked to Nick Shikuma San Diego State University, Charles Ericson ETH Zürich, & NanoSyrinx to learn more. #NationalNanoDay ow.ly/qzBF50L4Nfc

Congratulations to NanoSyrinx for winning the #AbbVieUKGoldenTicket last month👏

Want to hear a great explainer in simple terms about what NanoSyrinx is busy building? Head on over to Spin Up Science Ventures on #youtube to learn all about #drugdelivery using natures own toolkit with #synbio linkedin.com/posts/jrjheale…

Drug delivery progress is moving at a rapid rate. Innovations in the field will prove crucial in shaping the future of biotech. Leading the way is NanoSyrinx, a winner of our Golden Ticket programme. Discover how they harness 'nature's own toolkit' below 👇

Our second Pioneer Group partnership with AbbVie UK saw NanoSyrinx - a company revolutionising how medicines are administered - become the second winner of our Golden Ticket programme, joining @ImmtuneTx on-site in Nottingham.

Our CEO Joe Healey and CBO James Lapworth are at the 19th Anglonordic today. Feel free to pull us aside for a coffee (or something stronger!) if you'd like to learn more about our upcoming Series A fundraise.

Next week we look forward to joining pioneering 🇬🇧 companies like bit.bio, Evonetix, Colorifix, BioIndustry Association (BIA), Basecamp Research, Biome Bioplastics, Yourgene Health, FabricNano, bronic & NanoSyrinx in City of Oakland for SynBioBeta, the largest synthetic biology industry conference.

Our CEO Joe Healey is at SynBioBeta again this year. A bit thank you to the SBB team and Ginkgo Bioworks for awarding us a startup prize to attend for free! Looking forward to catching up with friends new and old! #SynBioBeta2023 #syntheticbiology

📣NEW ARTICLE: 🧬NanoSyrinx 🎱Aim: craft intracellular meds 🔑Key: engineer nano-syringes for versatile precision meds ⏭️Next: target selected diseases (oncology, longevity, metabolic,...) 🎙️Bonus: Dive into their journey, CEO insights & startup advice! buff.ly/3F6oYHW

We are delighted to be showcased as one of the 50 companies in PwC UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more here: bit.ly/46XfHhw #LifeSciences #BioTech #DigitalHealth #PwCFuture50

Future Planet Capital is proud to back five of the companies that have been highlighted in PwC’s Life Sciences Future50 – making up 10% of those selected. Congratulations to Ultromics , ONI , @Synthace, NanoSyrinx and Crescendo Biologics. 👉bit.ly/3QoWFd3 #LifeScience

How do you find the right cell & gene outsourcing partner, and ensure that the partnership benefits both parties? Join us for ‘You’re the Cell to my Gene’ at Advanced Therapies Integrates on 30th Nov hosted by StevenageBioscience lifescienceintegrates.com/event/advanced… #AdvancedTherapiesIntegrates

Big News 📢 Going in to a packed Jeffries week, we're excited to announce the appointment of Tony Johnson to our Board as an NED. Tony will help take NanoSyrinx to the next level as we build through Series A linkedin.com/posts/nanosyri… #drugdelivery #leadership #syntheticbiology

.NanoSyrinx today announced Anthony Johnson M.D. has joined its Board as Non-Executive Director. Tony’s appointment forms part of NanoSyrinx’ strategy to strengthen the leadership team as it prepares for the next stage in its development. Read more here: rb.gy/zehnsk

.NanoSyrinx today announced the close of a £10M financing round to advance its nanosyringe platform & appointed Dr Edwin Moses as Chairman. Edwin is a high-profile C-level executive with an impressive track record building & scaling biotech companies: rb.gy/ojyk0m

Congratulations to NanoSyrinx after completing a £10 million #financing round!! #NEWS More here: warwick.ac.uk/services/innov…

Today we have the great pleasure of announcing a £10M financing round to advance our nanosyringe platform as well as the appointment Dr. Edwin Moses as Chair. Find out more here: linkedin.com/posts/nanosyri… Read the PR here: nanosyrinx.com/2024/09/10/nan… #biotech #engbio #fundraising